![Foto de ÁNGEL](/img/nophoto.png)
ÁNGEL
CUESTA MARTÍNEZ
Profesor ayudante doctor
Publications (41) ÁNGEL CUESTA MARTÍNEZ publications
2024
-
CRISPR/Cas9 screenings unearth protein arginine methyltransferase 7 as a novel essential gene in prostate cancer metastasis
Cancer Letters, Vol. 588
-
Endothelial-to-Mesenchymal Transition in an Hereditary Hemorrhagic Telangiectasia-like Pediatric Case of Multiple Pulmonary Arteriovenous Malformations
International Journal of Molecular Sciences, Vol. 25, Núm. 11
-
Molecular and Cellular Characterization of Primary Endothelial Cells from a Familial Cavernomatosis Patient
International Journal of Molecular Sciences, Vol. 25, Núm. 7
2023
-
Mutation in Chek2 triggers von Hippel-Lindau hemangioblastoma growth
Acta Neurochirurgica, Vol. 165, Núm. 12, pp. 4241-4251
-
New and Old Key Players in Liver Cancer
International Journal of Molecular Sciences, Vol. 24, Núm. 24
2022
-
A Novel Splicing Mutation in the ACVRL1/ALK1 Gene as a Cause of HHT2
Journal of Clinical Medicine, Vol. 11, Núm. 11
-
C3G down-regulation enhances pro-migratory and stemness properties of oval cells by promoting an epithelial-mesenchymal-like process
International journal of biological sciences, Vol. 18, Núm. 15, pp. 5873-5884
-
Hereditary Hemorrhagic Telangiectasia: Diagnosis and Management
Journal of Clinical Medicine
-
Propranolol: A “Pick and Roll” Team Player in Benign Tumors and Cancer Therapies
Journal of Clinical Medicine, Vol. 11, Núm. 15
-
The Role of Propranolol as a Repurposed Drug in Rare Vascular Diseases
International Journal of Molecular Sciences, Vol. 23, Núm. 8
2020
-
CLN5 in heterozygosis may protect against the development of tumors in a VHL patient
Orphanet Journal of Rare Diseases, Vol. 15, Núm. 1
-
Review of pharmacological strategies with repurposed drugs for hereditary hemorrhagic telangiectasia related bleeding
Journal of Clinical Medicine, Vol. 9, Núm. 6, pp. 1-22
-
Targeting β2-adrenergic receptors shows therapeutical benefits in clear cell renal cell carcinoma from von Hippel–Lindau disease
Journal of Clinical Medicine, Vol. 9, Núm. 9, pp. 1-30
2019
-
Deep Learning Reveals Cancer Metastasis and Therapeutic Antibody Targeting in the Entire Body
Cell, Vol. 179, Núm. 7, pp. 1661-1676.e19
-
Evaluation of the safety and effectiveness of oral propranolol in patients with von Hippel-Lindau disease and retinal hemangioblastomas: Phase III clinical trial
BMJ Open Ophthalmology, Vol. 4, Núm. 1
-
The β2-adrenergic receptor antagonist ICI-118,551 blocks the constitutively activated HIF signalling in hemangioblastomas from von Hippel-Lindau disease
Scientific Reports, Vol. 9, Núm. 1
2018
-
A tumor-targeted trimeric 4-1BB-agonistic antibody induces potent anti-tumor immunity without systemic toxicity
Nature Communications, Vol. 9, Núm. 1
-
PHD3 controls lung cancer metastasis and resistance to EGFR inhibitors through TGFa
Cancer Research, Vol. 78, Núm. 7, pp. 1805-1819
2016
-
EphrinB2 repression through ZEB2 mediates tumour invasion and anti-angiogenic resistance
Nature Communications, Vol. 7
-
Intramolecular trimerization, a novel strategy for making multispecific antibodies with controlled orientation of the antigen binding domains
Scientific Reports, Vol. 6